| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2474-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-865 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
1984-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1988-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba66953be062ad2256cc3660a529dc9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc219a9a5ce0d3e6cafcda521bfc23b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_581e2130bbb9ac5f09e82326737e94f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a3fc314b90b496b8d494ac785a459c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9e166e58d0f77d767b552f38156ac0 |
| publicationDate |
1988-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1242158-A |
| titleOfInvention |
Human monoclonal antibodies from lymphocytes of patients with malignant melanoma |
| abstract |
ABSTRACT A human monoclonal antibody producing hybridoma cell lines is formed by fusing a human myeloma cell line, a mouse myeloma cell line, or human lymphoblastoid cell line, with human lymphocytes from individuals having malignant melanoma. These human monoclonal antibodies are useful in diagnosis of diseases associated with cancers. |
| priorityDate |
1983-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |